Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
27193 | 193 | 29.6 | 50% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BREFELDIN C | Author keyword | 6 | 100% | 2% | 4 |
2 | LETOSTEINE | Author keyword | 2 | 67% | 1% | 2 |
3 | BREFELDIN A ANALOGUES | Author keyword | 1 | 100% | 1% | 2 |
4 | BREFELDIN A DERIVATIVES | Author keyword | 1 | 100% | 1% | 2 |
5 | POSTCOLUMN FLUORESCENCE DERIVATIZATION | Author keyword | 1 | 33% | 1% | 2 |
6 | ASYMMETRIC ALDOLIZATION | Author keyword | 1 | 50% | 1% | 1 |
7 | CANC TREATMENT DIAGNIHFAIRVIEW | Address | 1 | 50% | 1% | 1 |
8 | DESYMMETRIZATION REACTION | Author keyword | 1 | 50% | 1% | 1 |
9 | ENGN BIOCONVERS BIOPUNFICAT | Address | 1 | 50% | 1% | 1 |
10 | GAMMA LACTONE DERIVATIVE | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PRODRUG CANDIDATES | 7 | 67% | 3% | 6 |
2 | ENHANCED AQUEOUS SOLUBILITIES | 4 | 67% | 2% | 4 |
3 | ASCOTOXIN | 4 | 75% | 2% | 3 |
4 | SULFIDE DERIVATIVES | 4 | 46% | 3% | 6 |
5 | NATURAL BREFELDIN A | 3 | 100% | 2% | 3 |
6 | DECUMBIN | 3 | 60% | 2% | 3 |
7 | BREFELDIN | 2 | 67% | 1% | 2 |
8 | 7 EPI BREFELDIN A | 1 | 100% | 1% | 2 |
9 | ANTIBIOTIC CYANEIN | 1 | 100% | 1% | 2 |
10 | CYANEIN | 1 | 100% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Enantioselective total synthesis of (+)-brefeldin A and 7-epi-brefeldin A | 2004 | 23 | 64 | 36% |
High Throughput Extraction of Plant, Marine and Fungal Specimens for Preservation of Biologically Active Molecules | 2010 | 40 | 25 | 12% |
SYNTHESIS AND BIOLOGICAL-ACTIVITY OF HETEROALKYL ANALOGS OF THE BROADLEAF HERBICIDE ISOXABEN | 1991 | 0 | 1 | 100% |
ER-Golgi network-A future target for anti-cancer therapy | 2009 | 36 | 98 | 6% |
BIOLOGICAL EFFECTS OF THE ANTIBIOTIC BREFELDIN-A (DECUMBIN, CYANEIN, ASCOTOXIN, SYNERGISIDIN) - A RETROSPECTIVE | 1992 | 31 | 22 | 5% |
Characterization of Pigments of Prokaryotes and Their Use in Taxonomy and Classification | 2011 | 0 | 22 | 5% |
THE DISCOVERY AND DEVELOPMENT OF NEW ANTILEUKEMIC DRUGS | 1993 | 0 | 57 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC TREATMENT DIAGNIHFAIRVIEW | 1 | 50% | 0.5% | 1 |
2 | ENGN BIOCONVERS BIOPUNFICAT | 1 | 50% | 0.5% | 1 |
3 | NEUROBIOL CELLULAR PATHOL UNIT 6101 | 1 | 50% | 0.5% | 1 |
4 | UMR 6513 SYNTH ORGAN | 0 | 25% | 0.5% | 1 |
5 | HEIDELBERG UNIV BIOCHEM | 0 | 14% | 0.5% | 1 |
6 | PHARM MOL BIOL | 0 | 11% | 0.5% | 1 |
7 | DEV THER EUT PROGRAM CANC TREATMENT | 0 | 100% | 0.5% | 1 |
8 | DNA TOPOL SECTMOL PHARMACOL | 0 | 100% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000117592 | CITREOVIRIDIN//BIOLOGICAL DIELS ALDER REACTION//MACROPHOMATE SYNTHASE |
2 | 0.0000095363 | MACROSPHELIDE//MICROCARPALIDE//ASPICILIN |
3 | 0.0000075684 | CARBACYCLIN//CARBACYCLINS//SM 10906 |
4 | 0.0000074423 | ELECTRON TRANSFERRING FLAVOPROTEIN//ACYL COA DEHYDROGENASE//2 4 DIENOYL COA REDUCTASE |
5 | 0.0000074278 | ALANGIACEAE//ALANGIUM LAMARCKII//ALANGIUM SALVIIFOLIUM |
7 | 0.0000069116 | ACTINOSYNNEMA PRETIOSUM//ANSAMITOCINS//ANSAMITOCIN |
8 | 0.0000067561 | ENOYL ACP REDUCTASE//ACYL CARRIER PROTEIN//FABH |
9 | 0.0000067329 | CYTOCHROME B5//NADH CYTOCHROME B5 REDUCTASE//RECESSIVE CONGENITAL METHEMOGLOBINEMIA |
10 | 0.0000063411 | LASALOCID ESTER//MONENSIN A//SALINOMYCIN |